JACOBS CINDY
Insider CIK 1229762 · OGXI President & CMO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2025-09-04 | 2025-09-08 | 84,000 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2025-09-04 | 2025-09-08 | 26,000 | — | $0 | 104,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2025-09-04 | 2025-09-08 | 110,000 | — | $0 | 143,214 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | S Sale | 2025-09-04 | 2025-09-08 | 27,629 | $2.77 | $76.5K | 115,585 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2025-01-28 | 2025-01-30 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award | 2024-08-16 | 2024-08-20 | 2,660 | $3.67 | $9.8K | 33,214 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2024-04-19 | 2024-04-23 | 16,250 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2024-04-19 | 2024-04-23 | 3,957 | $4.51 | $17.8K | 30,554 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2024-04-19 | 2024-04-23 | 16,250 | — | $0 | 34,511 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2024-01-22 | 2024-01-24 | 36,000 | — | $0 | 36,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2024-01-22 | 2024-01-24 | 84,000 | — | $0 | 84,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2023-04-28 | 2023-05-01 | 2,500 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2023-04-28 | 2023-05-01 | 609 | $8.29 | $5.0K | 18,261 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2023-04-28 | 2023-05-01 | 2,500 | — | $0 | 18,870 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2023-04-21 | 2023-04-24 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2023-04-21 | 2023-04-24 | 16,250 | — | $0 | 20,181 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2023-04-21 | 2023-04-24 | 4,819 | $6.80 | $32.8K | 15,362 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2023-04-21 | 2023-04-25 | 3,811 | $6.80 | $25.9K | 16,370 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2023-01-25 | 2023-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2023-01-25 | 2023-01-27 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award | 2022-08-16 | 2022-08-18 | 1,817 | $4.37 | $7.9K | 3,931 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2022-04-28 | 2022-04-29 | 2,500 | — | $0 | 2,500 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2022-04-28 | 2022-04-29 | 2,500 | — | $0 | 2,723 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2022-04-28 | 2022-04-29 | 609 | $7.43 | $4.5K | 2,114 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2022-01-03 | 2022-01-05 | 32,500 | — | $0 | 32,500 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2022-01-03 | 2022-01-05 | 32,500 | — | $0 | 32,500 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2021-08-17 | 2021-08-19 | 68 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2021-08-17 | 2021-08-19 | 68 | — | $0 | 244 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2021-08-17 | 2021-08-19 | 21 | $6.81 | $143 | 223 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2021-01-26 | 2021-01-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2021-01-26 | 2021-01-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2020-11-16 | 2020-11-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2020-08-18 | 2020-08-19 | 69 | — | $0 | 68 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2020-08-18 | 2020-08-19 | 69 | — | $0 | 209 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2020-08-18 | 2020-08-19 | 33 | $8.95 | $295 | 176 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2020-01-28 | 2020-01-30 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2019-08-13 | 2019-08-15 | 1,370 | — | $0 | 2,740 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2019-01-29 | 2019-01-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2019-01-29 | 2019-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2019-01-15 | 2019-01-17 | 42 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2019-01-15 | 2019-01-17 | 42 | — | $0 | 1,852 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2019-01-15 | 2019-01-17 | 13 | $1.16 | $15 | 1,839 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2018-09-20 | 2018-09-21 | 37,000 | — | $0 | 37,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2018-08-13 | 2019-08-15 | 408 | $1.88 | $767 | 2,801 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2018-08-13 | 2019-08-15 | 1,370 | — | $0 | 3,209 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2018-08-13 | 2018-08-15 | 45 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2018-08-13 | 2018-08-15 | 43 | — | $0 | 42 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2018-08-13 | 2018-08-15 | 1,370 | — | $0 | 4,110 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise deriv | 2018-08-13 | 2018-08-15 | 28 | — | $0 | 0 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | F Tax w/h | 2018-08-13 | 2018-08-15 | 472 | $2.78 | $1.3K | 1,810 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | M Exercise | 2018-08-13 | 2018-08-15 | 1,486 | — | $0 | 2,282 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2018-07-26 | 2018-07-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-08-03 | 54,800 | — | $0 | 54,800 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-08-03 | 274,000 | — | $0 | 274,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-09-12 | 274,000 | — | $0 | 274,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-06-12 | 2017-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2017-06-12 | 2017-06-14 | 1,633 | $0.36 | $588 | 87,726 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2017-06-12 | 2017-06-14 | 5,000 | — | $0 | 89,359 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-01-10 | 2017-01-12 | 2,500 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-01-10 | 2017-01-12 | 4,687 | — | $0 | 9,375 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2017-01-10 | 2017-01-12 | 3,125 | — | $0 | 3,125 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2017-01-10 | 2017-01-12 | 10,312 | — | $0 | 87,728 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2017-01-10 | 2017-01-12 | 3,369 | $0.63 | $2.1K | 84,359 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-06-13 | 2016-06-15 | 5,000 | — | $0 | 10,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2016-06-13 | 2016-06-15 | 1,437 | $1.03 | $1.5K | 77,416 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-06-13 | 2016-06-15 | 5,000 | — | $0 | 78,853 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2016-03-15 | 2016-03-16 | 3,254 | $0.83 | $2.7K | 73,853 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2016-03-14 | 2016-03-16 | 135,000 | — | $0 | 135,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-03-14 | 2016-03-16 | 4,688 | — | $0 | 14,062 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-03-14 | 2016-03-16 | 1,875 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-03-14 | 2016-03-16 | 2,500 | — | $0 | 2,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2016-03-14 | 2016-03-16 | 3,125 | — | $0 | 6,250 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2016-03-14 | 2016-03-16 | 12,188 | — | $0 | 77,107 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-06-12 | 2015-06-16 | 5,000 | — | $0 | 15,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2015-06-12 | 2015-06-16 | 1,408 | $2.69 | $3.8K | 64,919 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-06-12 | 2015-06-16 | 5,000 | — | $0 | 66,327 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2015-05-20 | 2015-05-21 | 2,092 | $1.88 | $3.9K | 61,327 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-19 | 2015-05-21 | 2,500 | — | $0 | 5,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-19 | 2015-05-21 | 1,875 | — | $0 | 1,875 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-19 | 2015-05-21 | 18,750 | — | $0 | 18,750 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-05-19 | 2015-05-21 | 3,125 | — | $0 | 9,375 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2015-05-19 | 2015-05-21 | 37,500 | — | $0 | 37,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-05-19 | 2015-05-21 | 7,500 | — | $0 | 63,419 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2015-01-30 | 2015-01-30 | 4,376 | $2.11 | $9.2K | 55,919 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2015-01-27 | 2015-01-30 | 13,400 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2015-01-27 | 2015-01-30 | 13,400 | — | $0 | 60,295 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2014-09-19 | 2014-09-19 | 1,310 | $3.06 | $4.0K | 46,895 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-09-17 | 2014-09-19 | 4,950 | — | $0 | 13,400 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-09-17 | 2014-09-19 | 4,950 | — | $0 | 48,205 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2014-08-13 | 2014-08-14 | 5,650 | $3.17 | $17.9K | 43,255 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-08-12 | 2014-08-14 | 20,000 | — | $0 | 0 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-08-12 | 2014-08-14 | 20,000 | — | $0 | 48,905 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-12 | 2014-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-06-12 | 2014-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2014-03-17 | 2014-03-18 | 1,250 | $12.25 | $15.3K | 28,905 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-03-14 | 2014-03-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-03-14 | 2014-03-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-03-14 | 2014-03-18 | 1,875 | — | $0 | 3,750 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2014-03-14 | 2014-03-18 | 2,500 | — | $0 | 7,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2014-03-14 | 2014-03-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2014-03-14 | 2014-03-18 | 4,375 | — | $0 | 30,155 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2013-08-19 | 2013-10-07 | 1,364 | $8.68 | $11.8K | 25,780 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2013-08-13 | 2013-08-15 | 4,593 | — | $0 | 11,375 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2013-08-13 | 2013-08-15 | 1,293 | — | $0 | 25,851 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2013-08-13 | 2013-08-15 | 4,593 | — | $0 | 27,144 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | S Sale | 2013-03-12 | 2013-10-07 | 534 | $11.90 | $6.4K | 22,551 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-03-12 | 2013-03-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise deriv | 2013-03-12 | 2013-03-14 | 1,875 | — | $0 | 5,625 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-03-12 | 2013-03-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2013-03-12 | 2013-03-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | M Exercise | 2013-03-12 | 2013-03-14 | 1,875 | — | $0 | 23,085 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | F Tax w/h | 2013-03-12 | 2013-03-14 | 534 | — | $0 | 22,551 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| OGXI ONCOGENEX PHARMACEUTICALS, | A Award deriv | 2012-05-08 | 2012-05-10 | 7,500 | — | $0 | 7,500 | SEC↗ |